Tumor strengths and frailties: Aspiring to prevent colon cancer

Nature Medicine

Volumn 18, Issue 1, 2012, Pages 32-33

  Maxwell, Patrick H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2;

CANCER MORTALITY; CANCER RISK; COLORECTAL CANCER; ENZYME INHIBITION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ASPIRIN; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FOLLOW-UP STUDIES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84855542051     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2637     Document Type: Short Survey

References (12)

1. Oshima, M. et al. Cell 87, 803-809 (1996).
2. Thun, M.J., Namboodiri, M.M. & Heath, C.W. Jr. N. Engl. J. Med. 325, 1593-1596 (1991).
3. Rothwell, P.M. et al. Lancet 377, 31-41 (2011).
4. Burn, J. et al. N. Engl. J. Med. 359, 2567-2578 (2008).
5. Burn, J. et al. Lancet published online, doi:10.1016/S0140-6736(11)61049- 0 (28 October 2011).
6. Yeomans, N.D. J. Gastroenterol. Hepatol. 26, 426-431 (2011).
7. Cuzick, J. et al. Lancet Oncol. 10, 501-507 (2009).
8. Baigent, C. et al. Lancet 373, 1849-1860 (2009).
9. Medema, J.P. & Vermeulen, L. Nature 474, 318-326 (2011).
10. Wang, D. & Dubois, R.N. Oncogene 29, 781-788 (2010).
11. Duthie, G.G. & Wood, A.D. Food Funct. 2, 515-520 (2011).
12. Aune, D. et al. Gastroenterology 141, 106-118 (2011).